retatrutide phase 2 trial type 2 diabetes weight loss 2024 💉 A triple-action once-weekly injection can significantly lower blood sugar and body in people with diabetes, a new 3 shows. is part of an emerging generation Triple hormone receptor agonist retatrutide

Similarly, patients with a history of gastric bypass, gastric banding, or other weight-loss surgery may experience compounded nausea, vomiting, or obstruction when combining GLP-1 therapy with prior anatomical changes

ER antagonists reduce MBOAT1 expression and sensitize cells to ferroptosis inducers (35)

GLP-1 agonists contribute to weight loss by slowing the rate at which the stomach empties

Microdosing GLP1s for Menopause In an effort to minimize side effects (and in some cases, reduce cost), some women are turning to microdosing GLP-1s for menopause weight loss

This delay, combined with increased calorie burning through thermogenesis, makes Semaglutide GLP-1 an effective tool for managing weight

M.Orbn-KisK.SzatmriS.et al (2025)